1. Home
  2. BOSC vs RNAZ Comparison

BOSC vs RNAZ Comparison

Compare BOSC & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B.O.S. Better Online Solutions

BOSC

B.O.S. Better Online Solutions

HOLD

Current Price

$4.24

Market Cap

29.9M

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$1.68

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOSC
RNAZ
Founded
1990
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
27.9M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
BOSC
RNAZ
Price
$4.24
$1.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.0K
★ 48.9K
Earning Date
11-30-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.00
N/A
Revenue Next Year
$9.70
N/A
P/E Ratio
$8.97
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.80
$1.52
52 Week High
$6.72
$13.92

Technical Indicators

Market Signals
Indicator
BOSC
RNAZ
Relative Strength Index (RSI) 24.74 46.15
Support Level $3.80 $1.55
Resistance Level $4.66 $1.93
Average True Range (ATR) 0.12 0.17
MACD -0.05 0.07
Stochastic Oscillator 13.57 65.85

Price Performance

Historical Comparison
BOSC
RNAZ

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of comprehensive solutions to enterprises, comprised of services, equipment, and custom-made automatic machines. The company manages its business in three reportable divisions: the Supply Chain Solutions Division, the RFID Division, and the Intelligent Robotics Division. The majority of revenue derives from Supply Chain Solutions, which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their component-supply needs. Its geographic areas are Israel, East Asia, India, America, Europe, and the rest of the world. Geographically company derives the majority of its revenue from Israel.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: